🔴 Picard Medical is trading 5.45% down today in pre-market after fiduciary-duty investigation announcement

Picard Medical is trading 5.45% down at $9.03 after the August 25, 2026 shareholder-investigation announcement.

• Bragar Eagel & Squire said it is investigating potential fiduciary-duty claims tied to alleged social-media promotion, nominee accounts, and omitted risk disclosures.
• Two advances of 59.81% and 86.16% followed an exceptionally volatile August 25, 2026 session, increasing concern about volatility and potential reversal.
• No new earnings release or confirmed overnight operational catalyst was identified; broader market mixed, and direct causation remains unconfirmed.